Skip to content

Effect of Platelet-Rich Fibrin on the stability of Bone Graft and soft tissues around dental implants: a randomized clinical trial

Guided Bone Regeneration in the maxilla with the use of Xenogeneic Graft associated or not with Platelet-Rich Fibrin: a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-10m7c788
Enrollment
Unknown
Registered
2022-09-23
Start date
2022-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar ridge atrofy without teeth

Interventions

The present study is a two-arm, double-blind, randomized controlled clinical trial. Eighteen maxillary edentulous patients will be included, with loss of bone thickness that prevents the placement of
the other side (control) will receive the same type and amount of bone graft without i-PRF. The experimental and control sides will be defined by randomization using tickets with the terms “i-prf” and

Sponsors

Faculdade Paulo Picanço
Lead Sponsor
Faculdade Paulo Picanço
Collaborator

Eligibility

Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Volunteers aged between 20 and 80 years; both genders

Exclusion criteria

Exclusion criteria: Partially dentate volunteers; with jaws without adequate bone height; uncontrolled systemic disease; smokers; history of radiation in the treatment area

Design outcomes

Primary

MeasureTime frame
Increased bone thickness of edentulous maxillae after bone regeneration using i-PRF associated with xenogenous particulate bone compared to the control side.

Secondary

MeasureTime frame
Stability of bone and soft tissues around the implants placed in the grafted regions, as well as the survival of implants in the grafted areas.

Countries

Brazil

Contacts

Public ContactAtais Bacchi

Faculdade Paulo Picanço

atais_bacchi@yahoo.com.br+55(54)981480520

Outcome results

None listed

Source: REBEC (via WHO ICTRP)